Instruments — Consolidated revenues
Thermo Fisher Scientific Instruments — Consolidated revenues decreased by 30.0% to $1.56B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.4%, from $1.63B to $1.56B. Over 4 years (FY 2021 to FY 2025), Instruments — Consolidated revenues shows relatively stable performance with a -1.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests strong demand for capital equipment and successful product innovation, while a decrease may indicate market saturation or a slowdown in customer capital expenditure budgets.
Detailed definition
This metric represents the total net sales generated by the business unit focused on scientific instruments and analytic...
Peer comparison
Comparable to capital equipment revenue segments in life sciences and analytical instrumentation peers, often sensitive to macroeconomic cycles and R&D spending trends.
tmo_segment_instruments_consolidated_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.84B | $1.82B | $2.2B | $1.91B | $2.01B | $1.93B | $2.08B | $1.9B | $1.84B | $1.87B | $2.04B | $1.63B | $1.8B | $1.77B | $2.25B | $1.63B | $1.64B | $1.81B | $2.22B | $1.56B |
| QoQ Change | — | -1.4% | +21.3% | -13.4% | +5.4% | -3.9% | +7.4% | -8.5% | -3.2% | +1.6% | +9.3% | -20.3% | +10.6% | -1.7% | +27.2% | -27.7% | +1.0% | +10.2% | +22.6% | -30.0% |
| YoY Change | — | — | — | — | +9.1% | +6.4% | -5.8% | -0.5% | -8.6% | -3.3% | -1.6% | -14.3% | -2.1% | -5.3% | +10.2% | -0.1% | -8.7% | +2.4% | -1.3% | -4.4% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's instruments — consolidated revenues?
- Thermo Fisher Scientific (TMO) reported instruments — consolidated revenues of $1.56B in Q1 2026.
- How has Thermo Fisher Scientific's instruments — consolidated revenues changed year-over-year?
- Thermo Fisher Scientific's instruments — consolidated revenues decreased by 4.4% year-over-year, from $1.63B to $1.56B.
- What is the long-term trend for Thermo Fisher Scientific's instruments — consolidated revenues?
- Over 4 years (2021 to 2025), Thermo Fisher Scientific's instruments — consolidated revenues has grown at a -1.5% compound annual growth rate (CAGR), from $7.75B to $7.3B.
- What does instruments — consolidated revenues mean?
- The total revenue generated from the sale of scientific instruments and analytical hardware equipment.